Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Safety, Tolerability, Pharmacokinetics and Pharmacodynamics”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT05864144
What this trial is testing

SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor, AdultAdvanced Solid TumorHead and Neck Cancer+19 more
Sensei Biotherapeutics, Inc. 98
Early research (Phase 1)Study completedNCT05625334
What this trial is testing

Study to Compare the Pharmacodynamics and Pharmacokinetics of Acetylsalicylic Acid Powder for Oral Inhalation With Non-enteric-coated Chewable Aspirin in Healthy Adults.

Who this might be right for
Healthy Volunteers
Vectura, Inc. 86
Early research (Phase 1)Study completedNCT03294707
What this trial is testing

Single and Multiple Ascending Dose Study Assessing the Safety, Tolerability, PK and PD of AG10

Who this might be right for
Amyloid Cardiomyopathy, Transthyretin-Related
Eidos Therapeutics, a BridgeBio company 56
Early research (Phase 1)Study completedNCT06972992
What this trial is testing

Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASC47 in Combination With Semaglutide

Who this might be right for
Chronic Weight Management
Ascletis Pharma (China) Co., Limited 28
Very early researchStudy completedNCT04559971
What this trial is testing

Evaluate the Safety, Tolerability, PK and PD of SLN124 in Healthy Volunteers

Who this might be right for
Healthy Volunteers
Silence Therapeutics plc 24
Early research (Phase 1)UnknownNCT04175704
What this trial is testing

Evaluating the Safety and Tolerability and Determining the PK and PD of Single Dose UB-221 in Chronic Spontaneous Urticaria

Who this might be right for
Chronic Idiopathic Urticaria
United BioPharma 32
Early research (Phase 1)Ended earlyNCT01164904
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181 in Healthy Subjects and Subjects With Mild to Moderate Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Amgen 72
Early research (Phase 1)Study completedNCT00739232
What this trial is testing

Single Ascending Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HSD-016

Who this might be right for
Healthy Subjects
Wyeth is now a wholly owned subsidiary of Pfizer 74
Early research (Phase 1)Study completedNCT07202663
What this trial is testing

Study of BB-025, Alone and After BB-031, in Healthy Volunteers

Who this might be right for
PharmacodynamicsPharmacokineticsHealthy Volunteers
Basking Biosciences, Inc. 72
Testing effectiveness (Phase 2)Study completedNCT03310021
What this trial is testing

A Healthy Volunteer Pharmacokinetics (PK)/Pharmacodynamics (PD), Safety and Tolerability Study of Andexanet in Healthy Japanese and Caucasian Subjects

Who this might be right for
Bleeding
Portola Pharmaceuticals 108
Early research (Phase 1)Study completedNCT06670950
What this trial is testing

Single Dose and Multiple Ascending Dose Study to Assess the Relative Bioavailability, Food Effect, Safety, Tolerability and Pharmacokinetics of SYT-510 in Healthy Participants

Who this might be right for
Healthy
Synendos Therapeutics AG 28
Early research (Phase 1)Study completedNCT03980080
What this trial is testing

Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of OSE-127 in Healthy Subjects

Who this might be right for
Healthy Subjects
OSE Immunotherapeutics 63
Early research (Phase 1)Study completedNCT01511497
What this trial is testing

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study Of PF-04427429 In Healthy Women Volunteers

Who this might be right for
PainMigraine Disorders
Pfizer 31
Early research (Phase 1)Active Not RecruitingNCT07119125
What this trial is testing

A First-in-human, 3-part Study of MRT-8102 in Healthy Participants and Participants at Cardiovascular Risk With Elevated CRP

Who this might be right for
Healthy VolunteersElevated CRP
Monte Rosa Therapeutics, Inc 100
Early research (Phase 1)Not Yet RecruitingNCT06897813
What this trial is testing

A Phase I Randomised, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect of WD-910 in Healthy Participants

Who this might be right for
Healthy Participants
Zhejiang Wenda Pharma Technology LTD. 68
Early research (Phase 1)Looking for participantsNCT07532018
What this trial is testing

DXP-106 in Solid Tumor Patients.

Who this might be right for
Solid TumorCancer
Singlomics Biopharmaceuticals Zhuhai Co., Ltd. 54
Early research (Phase 1)Study completedNCT02257489
What this trial is testing

Phase 1 Study of ACE-083 in Healthy Subjects

Who this might be right for
Musculoskeletal Diseases
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA 58
Testing effectiveness (Phase 2)WithdrawnNCT06622668
What this trial is testing

NTLA-3001 in Adults with Alpha-1 Antitrypsin Deficiency-Associated Lung Disease

Who this might be right for
Lung DiseasePulmonary DiseaseAATD+2 more
Intellia Therapeutics
Testing effectiveness (Phase 2)Study completedNCT01002950
What this trial is testing

Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACU-4429 in Subjects With Geographic Atrophy

Who this might be right for
Dry Age-related Macular DegenerationGeographic Atrophy
Kubota Vision Inc. 72
Early research (Phase 1)Study completedNCT01879020
What this trial is testing

Evaluation of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TA-8995 After Multiple Doses in Healthy Subjects

Who this might be right for
Dyslipidemia
Tanabe Pharma Corporation 61
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation